Format

Send to

Choose Destination
Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v16-7. doi: 10.1093/rheumatology/ken280.

Macrovascular disease in systemic sclerosis: the tip of an iceberg?

Author information

1
Vascular and Inflammatory Diseases Research Unit, Ninewells Hospital, Tayside, Scotland, UK. J.J.F.Belch@dundee.ac.uk

Abstract

This mini review evaluates mortality in SSc and provides a literature review concluding that premature death does occur in this population. However, there has been a changing spectrum of cause of death over the past three decades, with interstitial lung disease now being the commonest cause of SSc-related mortality. Cardiovascular (CV) mortality and events also contribute to the premature mortality seen in these patients, and this contention is supported by epidemiological studies, and further underpinned by a plethora of increased biomarkers for CV disease and events. Thus, macrovascular disease does occur in these patients, and is likely to contribute to mortality. It remains to be seen whether addressing conventional risk factors will attenuate CV disease in this population.

PMID:
18784129
DOI:
10.1093/rheumatology/ken280
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center